Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines

After worldwide implementation of 10-valent and 13-valent pneumococcal conjugate vaccines (PCV10/PCV13), a 20-valent PCV (PCV20) was developed. We assessed dynamics of non-PCV13 additional PCV20 serotypes (VT20–13), compared with all other non-VT20 serotypes, in children <2 years of age in late P...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben-Shimol, Shalom, Givon-Lavi, Noga, Kotler, Leore, Adriaan van der Beek, Bart, Greenberg, David, Dagan, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774550/
https://www.ncbi.nlm.nih.gov/pubmed/33350916
http://dx.doi.org/10.3201/eid2701.201178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774550/
https://www.ncbi.nlm.nih.gov/pubmed/33350916
http://dx.doi.org/10.3201/eid2701.201178

Ejemplares similares